181 related articles for article (PubMed ID: 22105582)
1. Interleukin-30: a novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine-induced liver injury.
Dibra D; Cutrera J; Xia X; Kallakury B; Mishra L; Li S
Hepatology; 2012 Apr; 55(4):1204-14. PubMed ID: 22105582
[TBL] [Abstract][Full Text] [Related]
2. IL-28A is a key regulator of T-cell-mediated liver injury via the T-box transcription factor T-bet.
Siebler J; Wirtz S; Weigmann B; Atreya I; Schmitt E; Kreft A; Galle PR; Neurath MF
Gastroenterology; 2007 Jan; 132(1):358-71. PubMed ID: 17241885
[TBL] [Abstract][Full Text] [Related]
3. Protective role of IL-33/ST2 axis in Con A-induced hepatitis.
Volarevic V; Mitrovic M; Milovanovic M; Zelen I; Nikolic I; Mitrovic S; Pejnovic N; Arsenijevic N; Lukic ML
J Hepatol; 2012 Jan; 56(1):26-33. PubMed ID: 21703183
[TBL] [Abstract][Full Text] [Related]
4. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines.
Fiorucci S; Santucci L; Antonelli E; Distrutti E; Del Sero G; Morelli O; Romani L; Federici B; Del Soldato P; Morelli A
Gastroenterology; 2000 Feb; 118(2):404-21. PubMed ID: 10648469
[TBL] [Abstract][Full Text] [Related]
5. IL-38 alleviates concanavalin A-induced liver injury in mice.
Yuan X; Li Y; Pan X; Peng X; Song G; Jiang W; Gao Q; Li M
Int Immunopharmacol; 2016 Nov; 40():452-457. PubMed ID: 27723569
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-30/IL27p28 Shapes Prostate Cancer Stem-like Cell Behavior and Is Critical for Tumor Onset and Metastasization.
Sorrentino C; Ciummo SL; Cipollone G; Caputo S; Bellone M; Di Carlo E
Cancer Res; 2018 May; 78(10):2654-2668. PubMed ID: 29487200
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-30 (IL27p28) alleviates experimental sepsis by modulating cytokine profile in NKT cells.
Yan J; Mitra A; Hu J; Cutrera JJ; Xia X; Doetschman T; Gagea M; Mishra L; Li S
J Hepatol; 2016 May; 64(5):1128-1136. PubMed ID: 26767500
[TBL] [Abstract][Full Text] [Related]
8. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice.
Louis H; Le Moine O; Peny MO; Quertinmont E; Fokan D; Goldman M; Devière J
Hepatology; 1997 Jun; 25(6):1382-9. PubMed ID: 9185757
[TBL] [Abstract][Full Text] [Related]
9. Role of interleukin-30 as a modulator of transcription signaling in liver injury.
Fujita T
Hepatology; 2012 Dec; 56(6):2424-5; author reply 2425. PubMed ID: 22619048
[No Abstract] [Full Text] [Related]
10. Mechanisms of concanavalin A-induced cytokine synthesis by hepatic stellate cells: Distinct roles of interferon regulatory factor-1 in liver injury.
Rani R; Kumar S; Sharma A; Mohanty SK; Donnelly B; Tiao GM; Gandhi CR
J Biol Chem; 2018 Nov; 293(48):18466-18476. PubMed ID: 30348900
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma is a therapeutic target molecule for prevention of postoperative adhesion formation.
Kosaka H; Yoshimoto T; Yoshimoto T; Fujimoto J; Nakanishi K
Nat Med; 2008 Apr; 14(4):437-41. PubMed ID: 18345012
[TBL] [Abstract][Full Text] [Related]
12. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.
Hong F; Jaruga B; Kim WH; Radaeva S; El-Assal ON; Tian Z; Nguyen VA; Gao B
J Clin Invest; 2002 Nov; 110(10):1503-13. PubMed ID: 12438448
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 5 signaling restrains T-cell/natural killer T-cell activation and protects against concanavalin A-induced hepatic injury.
Wang L; Zhang W; Ge CH; Yin RH; Xiao Y; Zhan YQ; Yu M; Li CY; Ge ZQ; Yang XM
Hepatology; 2017 Jun; 65(6):2059-2073. PubMed ID: 28273362
[TBL] [Abstract][Full Text] [Related]
14. Allo-transplantation of mesenchymal stem cells attenuates hepatic injury through IL1Ra dependent macrophage switch in a mouse model of liver disease.
Lee KC; Lin HC; Huang YH; Hung SC
J Hepatol; 2015 Dec; 63(6):1405-12. PubMed ID: 26276675
[TBL] [Abstract][Full Text] [Related]
15. Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel Disease.
Chiriac MT; Buchen B; Wandersee A; Hundorfean G; Günther C; Bourjau Y; Doyle SE; Frey B; Ekici AB; Büttner C; Weigmann B; Atreya R; Wirtz S; Becker C; Siebler J; Neurath MF
Gastroenterology; 2017 Jul; 153(1):123-138.e8. PubMed ID: 28342759
[TBL] [Abstract][Full Text] [Related]
16. Hepatoprotective Effect of Wedelolactone against Concanavalin A-Induced Liver Injury in Mice.
Luo Q; Ding J; Zhu L; Chen F; Xu L
Am J Chin Med; 2018; 46(4):819-833. PubMed ID: 29737211
[TBL] [Abstract][Full Text] [Related]
17. Effects of an intravitreal injection of interleukin-35-expressing plasmid on pro-inflammatory and anti-inflammatory cytokines.
Hou C; Wu Q; Ouyang C; Huang T
Int J Mol Med; 2016 Sep; 38(3):713-20. PubMed ID: 27460435
[TBL] [Abstract][Full Text] [Related]
18. Preventive effects of (5R)-5-hydroxytriptolide on concanavalin A-induced hepatitis.
Zhou R; Tang W; Ren YX; He PL; Yang YF; Li YC; Zuo JP
Eur J Pharmacol; 2006 May; 537(1-3):181-9. PubMed ID: 16603150
[TBL] [Abstract][Full Text] [Related]
19. Hyperproduction of proinflammatory cytokines by WSX-1-deficient NKT cells in concanavalin A-induced hepatitis.
Yamanaka A; Hamano S; Miyazaki Y; Ishii K; Takeda A; Mak TW; Himeno K; Yoshimura A; Yoshida H
J Immunol; 2004 Mar; 172(6):3590-6. PubMed ID: 15004160
[TBL] [Abstract][Full Text] [Related]
20. Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells.
Petrasek J; Dolganiuc A; Csak T; Nath B; Hritz I; Kodys K; Catalano D; Kurt-Jones E; Mandrekar P; Szabo G
Hepatology; 2011 Feb; 53(2):649-60. PubMed ID: 21274885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
